Park Ha Biological Technology Co., Ltd. key statistics and ratios

In fiscal 2025, Park Ha Biological Technology Co., Ltd. had an operating margin of -956.5%, debt equal to 0.0% of equity and a current ratio of 2.92. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Park Ha Biological Technology Co., Ltd.: financial ratios, annual
Fiscal year	2022Oct 2022	2023Oct 2023	2024Oct 2024	2025Oct 2025
Gross margin	73.5%	87.4%	91.8%	94.4%
Operating margin	10.3%	48.0%	33.3%	−956.5%
Net margin	10.0%	34.6%	20.1%	−965.0%
Free-cash-flow margin	74.5%	4.2%	36.7%	−0.1%
Return on equity	127.3%	146.6%	38.0%	—
Return on assets	—	37.6%	17.9%	−539.3%
Asset turnover	—	1.09	0.89	0.56
Current ratio	—	1.75	1.87	2.92
Debt to equity	0.0%	0.0%	0.0%	0.0%
Interest cover (operating income ÷ interest)	—	—	—	n/m
Effective tax rate	−0.7%	27.9%	39.7%	—
R&D as % of revenue	3.2%	1.3%	1.5%	9.4%
Capital spending as % of revenue	0.6%	0.9%	3.6%	3.5%
Free cash flow ÷ net income	747.7%	12.2%	182.8%	—

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

2 of 3 checks passed · October 31, 2025

What it owns · $6m

Short-term assets $6mLonger-term assets $0m

What it owes, and who funded it · $6m

Short-term liabilities $2mLonger-term liabilities $0mShareholders' equity $4m

Short-term assets cover short-term liabilities $6m of assets due within a year against $2m of liabilities due within a year.
Short-term assets cover long-term liabilities $6m short-term assets against $75,915 of longer-dated liabilities.
More cash than debt Cash or debt not separately reported. Not assessable.
Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
Operating profit covers interest at least five times over Operating income of −$24m against $41 of interest.

From Park Ha Biological Technology Co., Ltd.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: BYAH vs SNES BYAH vs ZONE BYAH vs CITR BYAH vs REFR

More: Specialty Chemicals stocks compared, Materials sector, rankings of US companies

Figures from Park Ha Biological Technology Co., Ltd.'s SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Park Ha Biological Technology Co., Ltd.